Then, by sophisticated proteomic approaches, the authors investigated the internalizing pathway of anti-CD46 antibodies and identified a mechanism of tumor-selective entry via micropinocytosis, leading to outstanding selective killing of cancer cells [54]. The gene discussed is CD46; the disease is neoplasm.